2009-2013 YILLARI ARASINDA TAKSİM-GAZİOSMANPAŞA EĞİTİM VE ARAŞTIRMA HASTANESİNDE OPERE EDİLEN JİNEKOLOJİK MALİGNİTE VAKALARININ RETROSPEKTİF DEĞERLENDİRİLMESİ Retrospective Evaluation Of Operated Gynecological Malignancies Between 2009-2013 in Gaziosmanpaşa - Taksim Training And Research Hospital

Year 2019, Volume: 9 Issue: 2, 58 - 66, 28.06.2019

Fatma Ketenci Gencer

Abstract

ÖZET

Amaç: İstanbul’da bir eğitim ve araştırma hastanesinde opere edilen jinekolojik kanser vakalarının sosyodemografik

karakteristiklerinin ve sıklıklarının değerlendirilmesi.

Gereç-Yöntem: Retrospektif düzenlenen bu çalışmada 2009-2013 yılları arasında opere edilen jinekolojik

kanser vakaları değerlendirildi. Hastane kayıt bilgileri eksiksiz olan 84 vaka çalışmaya dahil edildi. Vakaların

sosyo-demografik özellikleri, tanıları, yapılan ameliyat, ameliyat sonrası patoloji raporları, evre özellikleri

çalışma veri kaynakları olarak kullanıldı.

Bulgular: Vakaların %46’sı over, %30’u uterin korpus, %13,1’i serviks, %2,4’ü vulva ve %1,2’si vajen kanseridir.

%1,2 vakada primer peritoneal karsinom mevcuttur. Evre III-IV hastalık over kanserlerinde %42, endometriyum

kanserlerinde %20, serviks kanserinde %9’dur.Tüm vakaların yaş ortalaması 55,63 ± 13,72’dir. Ortalama term

doğum sayısı 2,35 ± 2,08, vücut kitle indeks ortalması 28,72 ± 2,55’tir. Vakaların yarıdan fazlasında başvuru

şikayeti pelvik ağrı ve postmenapozal kanamadır. Diğer başvuru şikayetleri düzensiz menstruasyon, abdominal

şişkinlik ve vajinal akıntıdır.

Sonuç: Bölgemizde over kanseri diğer jinekolojik kanserlerden daha sıktır. Ek olarak ileri evre hastalık, over

kanserlerinde daha sık olarak görülmektedir. Non-spesifik belirti olan pelvik ağrı jinekolojik kanserlerde sık

rastlanan bir semptomdur. Kadınların bu belirtiyi ihmal etmemelerinin sağlanması önemlidir.

Anahtar Sözcükler: Kadın genital tümörleri, ednometriyal neoplaziler, ovaryen neoplaziler, uterin servikal

neoplaziler

ABSTRACT

Aim: Evaluation of gynecological oncology cases performed in an educational research hospital in terms of

sociodemographic characteristics

Methods: In this retrospective study, the gynecological oncology cases performed between 2009 and 2013

were evaluated. 84 cases with complete hospital record information were included into the study. The sociodemographic

characteristics of the cases, the diagnoses, the operation performed, post-operative pathology

reports, stage characteristics were used as data sources.

Results: 46% of the cases were over, 30% were uterine corpus, 13,1% were cervix, 2,4% were vulva and 1,2%

were vaginal cancer. Primary peritoneal carcinoma was detected in 1,2% of cases. Stage III-IV disease is 42%

in over-cancer, 20% in endometrial cancer, and 9% in cervical cancer.The average age of all cases was 55,63 ±

13,72. The mean number of term births was 2,35 ± 2,08, the mean body mass index was 28,72 ± 2,55. More

than half of the complaints of our gynecological cancer cases were pelvic pain and postmenopausal bleeding.

Other complaints were irregular menstruation, abdominal swelling, vaginal discharge.

Conclusion: Over cancer in our region is more common than other gynecological cancers. In addition,

advanced disease is more common in over cancer. Pelvic pain, a non-specific symptom, is a common symptom

in gynecologic cancers. It should be ensured that women do not neglect this symptom.

Keywords: Female genital neoplasms, endometrial neoplasms, ovarian neoplasms, uterin cervical neoplasms

Keywords

2009-2013 YILLARI ARASINDA TAKSİM-GAZİOSMANPAŞA EĞİTİM VE ARAŞTIRMA HASTANESİNDE OPERE EDİLEN JİNEKOLOJİK MALİGNİTE VAKALARININ RETROSPEKTİF DEĞERLENDİRİLMESİ Retrospective Evaluation Of Operated Gynecological Malignancies Between 2009-2013 in Gaziosmanpaşa - Taksim Training And Research Hospital

References

• 1. Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016:A Systematic Analysis for the Global Burden of Disease Study. JAMAOncology June 2,2018. doi:10.1001/jamaoncol. 2018.2706. 2. Gultekin M, Dundar S, Kucukyildiz I, Karaca MZ, Boztas G, Turan SH, et al. Survival of gynecological cancers in Turkey: where are we at?J Gynecol Oncol. 2017;28(6):e85. 3. Pınar I, Algıer L, Doğan N, Kaya N. Determination of the Risk Factors in Individuals with Gynecological Cancer. Int J Hematol Oncol Stem Cell Res. 2008;(4):208-16. 4. Lyngea E, Lönnbergb S, Törnberg S. Cervical cancer incidence in elderly women-biology or screening history?Eur J Cancer. 2017;(74):82-8. 5. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papillomavirus–associated cancers-United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661-6. 6. Purdie DM, and GreenAC.Best Pract Res Clin Obstet Gynaecol;15(3):341-54. 7. Kheiri SA, Kunna A, Babiker AY, Alsuhaibani SA, Ahmed RY, Alsammani MA. Histopathological Pattern and Age Distribution of Malignant Ovarian Tumor among Sudanese Ladies. Maced J Med Sci. 2018;12;6(2):237-41. 8. Adegoke O,. KulasingamS, and VirnigB. Cervical cancer trends in the United States: a 35‐year population‐based analysis. J. Womens Health. 2012;(21):1031–7. 9. Eifel PJ, BurkeTW, MorrisM, and SmithTL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol. Oncol1995;(59):38–44. 10. Bray FB, Carstensen H, Møller H, ZappaM, ZakeljMP, LawrenceG, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol. Biomarkers Prev. 2005;(14):2191-9.